A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis

  • J. Koo
  • , B. Abrams
  • , G. Albrecht
  • , P. Altmeyer
  • , F. A. Bahmer
  • , S. Belaich
  • , J. Berth-Jones
  • , J. R. Bjerke
  • , J. D. Bos
  • , L. Braathen
  • , G. Burg
  • , D. Burrows
  • , A. Claudy
  • , L. A. Drake
  • , L. Dubertret
  • , R. Engst
  • , M. I. Ettelt
  • , E. Frenk
  • , P. J. Frosch
  • , J. Ganslandt
    • M. Goos, R. A.C. Graham-Brown, J. J. Guilhou, U. F. Haustein, S. Helland, K. Hutchinson, H. Jacobi, E. G. Jung, S. Kang, P. Kind, J. Knop, N. J. Lowe, T. Luger, G. Mahrle, R. Marks, H. Meffert, J. Meyer, N. J. Mørk, U. Mrowietz, H. A.M. Neumann, E. A. Olsen, S. Rogers, T. Ruzicka, A. G. Schmidt, E. Schöpf, J. L. Shupack, T. M. Starink, D. Tio, W. A. Van Vloten, B. J. Vermeer, U. Wollina

Research output: Contribution to journal › Article › peer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science